-+ 0.00%
-+ 0.00%
-+ 0.00%

Sino-Singapore Group (601512.SH) plans to invest no more than 20 million yuan in investment funds in the medical device and biotechnology sector

Zhitongcaijing·09/21/2026 08:41:09
Listen to the news

Zhitong Finance App News, Sino-Singapore Group (601512.SH) announced that the company intends to participate in the investment of Anhui Daotong Yaohui Equity Investment Partnership (Limited Partnership) with its own funds as a limited partner. The fund focuses on equity investment in the medical devices and biotechnology fields. The target fund plans to introduce multiple investors in this round. The total target size will not exceed 1.1 billion yuan. In the end, the actual fundraising situation will prevail. The company's pledged investment does not exceed 20 million yuan, and accounts for no more than 5% of the total amount pledged by the ultimate target fund.

This investment is in line with the company's strategic development plan. While obtaining financial returns, it helps the company optimize the industrial investment layout, thereby effectively complementing the park development and operation business chain, strengthening the main business of park development and operation, and enhancing the core competitiveness of the company's industrial park development and operation.